Arcturus Therapeutics Ltd.(ARCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ARCT Arcturus Therapeutics Ltd.

Market Closed 07-17 16:00:00 EDT

6.05

-0.13

-2.10%

盘后6.03

-0.02-0.33%

16:59 EDT

High6.18	Low6.00	Vol429.58K
Open6.09	D1 Closing6.18	Amplitude2.91%
Mkt Cap171.90M	Tradable Cap158.97M	Total Shares28.41M
T/O2.61M	T/O Rate1.63%	Tradable Shares26.28M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ARCT","market":"US","secType":"STK","nameCN":"Arcturus Therapeutics Ltd.","latestPrice":6.05,"timestamp":1784318400000,"preClose":6.18,"halted":0,"volume":429584,"hourTrading":{"tag":"盘后","latestPrice":6.03,"preClose":6.05,"latestTime":"16:59 EDT","volume":16756,"amount":101682.61,"timestamp":1784321977353,"change":-0.02,"changeRate":-0.003306,"amplitude":0.008264},"delay":0,"changeRate":-0.0210355987055016,"floatShares":26275300,"shares":28412537,"eps":-2.83921,"marketStatus":"Market Closed","change":-0.13,"latestTime":"07-17 16:00:00 EDT","open":6.09,"high":6.18,"low":6,"amount":2609050,"amplitude":0.029126,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.83921,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1784534400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":6.18,"preHourTrading":{"tag":"盘前","latestPrice":6.08,"preClose":6.18,"latestTime":"09:13 EDT","volume":348,"amount":2119.57926,"timestamp":1784294027678,"change":-0.1,"changeRate":-0.016181,"amplitude":0.050162},"postHourTrading":{"tag":"盘后","latestPrice":6.03,"preClose":6.05,"latestTime":"16:59 EDT","volume":16756,"amount":101682.61,"timestamp":1784321977353,"change":-0.02,"changeRate":-0.003306,"amplitude":0.008264},"volumeRatio":0.820177,"impliedVol":0.9907,"impliedVolPercentile":0.3267},"requestUrl":"/m/hq/s/ARCT","defaultTab":"news","newsList":[{"id":"2651439900","title":"Analysts Offer Insights on Healthcare Companies: Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF) and Arcturus Therapeutics (ARCT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651439900","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651439900?lang=en_us&edition=fundamental","pubTime":"2026-07-15 12:30","pubTimestamp":1784089846,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Fisher & Paykel Healthcare Corporation Limited (FSPKF) and Arctur...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-fisher-paykel-healthcare-corporation-limited-otherfspkf-and-arcturus-therapeutics-arct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-fisher-paykel-healthcare-corporation-limited-otherfspkf-and-arcturus-therapeutics-arct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK8004","XBI","FPH.NZ","BK4581","XLV","BK4082","BK4585","FSPKF","LABU","ARCT","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648068125","title":"U.S. Stocks on the Move-silicom, Blue Owl, Intel","url":"https://stock-news.laohu8.com/highlight/detail?id=2648068125","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648068125?lang=en_us&edition=fundamental","pubTime":"2026-07-03 00:19","pubTimestamp":1783009173,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Silicom, Blue Owl, IntelWorkspace search string for individual stock moves:STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nL6N4341RA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LHAI","ONTO","NEXA","FC","LCDL","UHS","YRD","NEM","MRNA","DLTR","SNDK","MRNY","TERG","ARCT","WBX","JPO","HSBA.UK","OWL","GE","KLAC","ELTX","SNXX","CVEO","LCIZ","HONA","SNDG","NWMX","TER","LINT","HCA","INTW","KLAG","AU","MRNX","SILC","SNDQ","SNDU","CWD","TMO","CLRO","SNDC","JPMO","OUST","RVNL","LCID","FPS","RIVN","MEI","INTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648681913","title":"Analysts Offer Insights on Healthcare Companies: Faeth Therapeutics (FTH) and Arcturus Therapeutics (ARCT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2648681913","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648681913?lang=en_us&edition=fundamental","pubTime":"2026-07-03 00:10","pubTimestamp":1783008609,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Faeth Therapeutics (FTH) and Arcturus Therapeutics (...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-faeth-therapeutics-fth-and-arcturus-therapeutics-arct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-faeth-therapeutics-fth-and-arcturus-therapeutics-arct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","FTH","BK4139","LU0128526141.USD","LABU","LU0029874061.USD","XBI","XLV","HCSG","BK4588","BK4137","BK4581","ARCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648274683","title":"Arcturus, Thermo Fisher deal adds support to ARCT-032 exposure, says Roth","url":"https://stock-news.laohu8.com/highlight/detail?id=2648274683","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648274683?lang=en_us&edition=fundamental","pubTime":"2026-07-02 21:55","pubTimestamp":1783000529,"startTime":"0","endTime":"0","summary":"Roth Capital analyst Adam Walsh keeps a Buy rating and $20 price target on shares of Arcturus Therapeutics (ARCT). The Thermo Fisher (TMO) collabor...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/arcturus-thermo-fisher-deal-adds-support-to-arct-032-exposure-says-roth-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/arcturus-thermo-fisher-deal-adds-support-to-arct-032-exposure-says-roth-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0122379950.USD","LU2089984988.USD","LU2360108059.USD","LU2125909759.SGD","BK4534","LU1280957306.USD","LU0061474960.USD","IE00B2B36J28.USD","LU0096362180.USD","LU2092937221.SGD","LU2764263039.SGD","IE00BQXX3D17.EUR","GB00BDT5M118.USD","LU0528227936.USD","IE00B4R5TH58.HKD","LU0011850046.USD","IE00BJT1NW94.SGD","IE0034235188.USD","LU2543165471.USD","LU2720916845.USD","BK4535","LU0316494557.USD","LU0957791311.USD","LU0114720955.EUR","BK4139","LU1720051108.HKD","LU1670628061.USD","LU1988902786.USD","LU2125910179.SGD","IE0002141913.USD","LU0208291251.USD","LU0266013472.USD","LU0882574055.USD","LU1923622614.USD","LU0345770993.USD","LU2125909916.SGD","IE00BQXX3F31.USD","LU1803068623.USD","TMO","LU2468319806.SGD","LU1548497426.USD","LU1854104046.USD","LU1989771016.USD","LU2125909247.SGD","IE00BKPKM429.USD","BK4588","BK4548","LU0823416689.USD","LU2211814178.USD","ARCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648688136","title":"U.S. Stocks on the MOVE- Dollar Tree, Rivian, Arcturus","url":"https://stock-news.laohu8.com/highlight/detail?id=2648688136","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648688136?lang=en_us&edition=fundamental","pubTime":"2026-07-02 21:22","pubTimestamp":1782998536,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Dollar Tree, Rivian, ArcturusWorkspace search string for individual stock moves:STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: h","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nL6N4340P0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","LU1923622614.USD","BK4570","BK4114","LU0055631609.USD","BK4157","LU0114720955.EUR","BK4139","LU2041044095.USD","LU2112291526.USD","LU2125909247.SGD","LU2462611646.USD","LU1670628061.USD","IE00B19Z8X17.USD","LU1023059063.AUD","LU0345780521.USD","LU0330918003.SGD","IE00B2B36J28.USD","LU1712237335.SGD","BK4548","LU0075056555.USD","LU0170899867.USD","LU1791710400.SGD","NWMX","LU0266512473.USD","LU0345770993.USD","LU2433249047.HKD","LU0432979614.USD","RIVN","LU2298321311.HKD","LU2360108059.USD","BK4555","BK4585","LU0345781412.USD","BK4155","BK4532","LU0300736062.USD","LU2125909916.SGD","DLTR","RVNL","SG9999001143.SGD","LU1035773651.USD","LU0300736492.USD","LU1069347547.HKD","LU2764262908.HKD","BK4522","BK4504","LU0654597011.USD","LU1791710582.SGD","LU1280957306.USD","LU2211815571.USD","BK4535","LU2063271972.USD","IE00B4R5TH58.HKD","LU0640476718.USD","LU1989771016.USD","LU0320765489.SGD","LU1983299246.USD","LU0011850046.USD","IE00BJT1NW94.SGD","LU0630314457.HKD","LU1720051017.SGD","OUST","NEMG","LU0612318971.USD","LU2543165471.USD","LU1720051108.HKD","LU1548497426.USD","LU1923622291.USD","AU","BK4566","HMY","IE00B19Z3581.USD","IE0002270589.USD","BK4182","IE00B19Z8W00.USD","LU0122379950.USD","LU1803068623.USD","IE00BQXX3F31.USD","BK4121","LU0006061336.USD","LU0456854461.SGD","LU2764263039.SGD","IE0009355771.USD","LU0368265764.SGD","LU1883866441.USD","LU1023059493.AUD","LU1102505929.USD","LU0266013472.USD","LU0143863198.USD","LU2211814178.USD","LU2468319806.SGD","IE00BKPKM429.USD","LU0234572021.USD","LU1223083913.SGD","LU0061474960.USD","LU2498475776.HKD","BK4588","LU1430597077.USD","BK4099","HONA","IE00BQXX3D17.EUR","ARCT","LU2125909759.SGD","TMO","LU1064131342.USD","LU1223082519.USD","LU2764263203.CNY","IE0034235188.USD","IE00B19Z3B42.SGD","LU0303821028.USD","LU1854104046.USD","LU0278409577.USD","LU1923621640.USD","LU1223082196.USD","LU0557290698.USD","LU0788109121.HKD","LU0498741890.SGD","LU0612318385.USD","LU0345770308.USD","LU0882574055.USD","IE00BJJMRZ35.SGD","LU0070302665.USD","LU0528227936.USD","LU2125910336.SGD","LU1102505762.USD","GB00BDT5M118.USD","IE00BFTCPJ56.SGD","LU1988902786.USD","BK4581","LU1868837565.USD","LU0724618789.USD","LU1854103824.USD","LU2264538146.SGD","IE00B19Z9505.USD","LU0496367417.USD","IE00B1BXHZ80.USD","LU0498741114.HKD","LU0345780950.USD","LU2720916845.USD","LU0345780281.USD","BK4533","LU0208291251.USD","LU0788108826.HKD","BK4547","FPS","LU0957791311.USD","LU0342679015.USD","LU2125910179.SGD","LU0823416689.USD","LU2089984988.USD","GFI","LU1153585028.USD","LU2125909593.SGD","LU1670627923.USD","IE0002141913.USD","LU1291159041.SGD","BK4017","LU1633808545.USD","LU0303823156.USD","IE00BQXX3C00.GBP","LU1057294990.SGD","LU1623119135.USD","LU2092937221.SGD","LU1868838027.USD","LU0096362180.USD","BK4534","LU0266512127.USD","LU1815333072.USD","LU2357305700.SGD","LU0316494557.USD","LU0143863784.USD","NEM","BK4596"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648025805","title":"Arcturus Rises on Thermo Fisher Collaboration for Rare Disease Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2648025805","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648025805?lang=en_us&edition=fundamental","pubTime":"2026-07-02 19:48","pubTimestamp":1782992914,"startTime":"0","endTime":"0","summary":"BUZZ-Arcturus rises on Thermo Fisher collaboration for rare disease drug** Shares of Arcturus TherapeuticsARCT.Orise 5.8% to $7.29 premarket** Co announces collaboration with Thermo Fisher ScientificT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nL4N4340W9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","IE00BQXX3D17.EUR","LU2125910336.SGD","LU0823416689.USD","LU2089984988.USD","LU1057294990.SGD","IE00B19Z8W00.USD","LU1854103824.USD","LU0011850046.USD","LU2125909916.SGD","IE00B2B36J28.USD","ARCT","LU1815333072.USD","LU0114720955.EUR","LU1923622291.USD","IE0034235188.USD","LU1548497426.USD","LU2041044095.USD","LU2543165471.USD","BK4534","IE00BQXX3C00.GBP","LU1988902786.USD","LU2125910179.SGD","LU1803068623.USD","LU1061106388.HKD","TMO","LU0316494557.USD","LU1923622614.USD","BK4566","LU1712237335.SGD","IE00BJJMRZ35.SGD","LU0320765489.SGD","LU0528227936.USD","LU2298321311.HKD","BK4585","LU2357305700.SGD","IE00B1BXHZ80.USD","LU1720051108.HKD","IE00BJT1NW94.SGD","LU0957791311.USD","LU0640476718.USD","IE00B19Z9505.USD","LU2125909593.SGD","LU0557290698.USD","LU2764262908.HKD","LU2433249047.HKD","LU1623119135.USD","LU0342679015.USD","IE00BFTCPJ56.SGD","LU2720916845.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648501760","title":"Arcturus Therapeutics Partners with Thermo Fisher to Support Phase 3 Development of Cystic Fibrosis Therapy Arct-032","url":"https://stock-news.laohu8.com/highlight/detail?id=2648501760","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648501760?lang=en_us&edition=fundamental","pubTime":"2026-07-02 19:00","pubTimestamp":1782990037,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics partners with Thermo Fisher to support Phase 3 development of cystic fibrosis therapy ARCT-032Arcturus entered a strategic collaboration with Thermo Fisher to support Phase 3 dev","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nNDLbW4bq6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0011850046.USD","LU1064131342.USD","LU0345770993.USD","IE00B2B36J28.USD","IE00BKPKM429.USD","LU1923622291.USD","BK4585","LU2125909759.SGD","LU2089984988.USD","LU2468319806.SGD","IE00BQXX3F31.USD","LU1548497426.USD","LU2125910336.SGD","LU1061106388.HKD","LU0320765489.SGD","GB00BDT5M118.USD","LU0070302665.USD","LU2125910179.SGD","LU1815333072.USD","LU0528227936.USD","BK4535","LU0234572021.USD","LU1712237335.SGD","BK4139","LU0061474960.USD","LU0640476718.USD","BK4588","TMO","LU1670627923.USD","LU0557290698.USD","ARCT","LU1720051108.HKD","LU2125909247.SGD","LU1988902786.USD","LU0957791311.USD","BK4121","LU2211814178.USD","LU0208291251.USD","BK4566","LU0432979614.USD","LU2264538146.SGD","LU1023059063.AUD","LU1923621640.USD","LU0096362180.USD","BK4534","IE00B19Z9505.USD","LU0823416689.USD","LU1670628061.USD","LU2360108059.USD","LU1803068623.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648501429","title":"Arcturus Therapeutics Holdings - Thermo Fisher to Receive Exclusive Commercial Manufacturing Rights for Arct-32","url":"https://stock-news.laohu8.com/highlight/detail?id=2648501429","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648501429?lang=en_us&edition=fundamental","pubTime":"2026-07-02 19:00","pubTimestamp":1782990000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nTUABDN7T4:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1988902786.USD","BK4581","LU1061106388.HKD","LU1854103824.USD","LU2211814178.USD","LU2468319806.SGD","IE00BKPKM429.USD","LU0061474960.USD","LU0114720955.EUR","LU2041044095.USD","BK4588","LU2112291526.USD","LU2125909247.SGD","LU1670628061.USD","LU1280957306.USD","LU1023059063.AUD","BK4533","IE00BQXX3D17.EUR","LU0208291251.USD","IE00B2B36J28.USD","LU0957791311.USD","BK4548","IE00B4R5TH58.HKD","ARCT","LU0342679015.USD","LU2125909759.SGD","LU2125910179.SGD","TMO","IE00BJT1NW94.SGD","LU2764263203.CNY","IE0034235188.USD","LU1791710400.SGD","LU1720051108.HKD","LU2125909593.SGD","LU1291159041.SGD","LU1923622291.USD","LU1057294990.SGD","LU0557290698.USD","LU1623119135.USD","LU2092937221.SGD","LU0882574055.USD","BK4585","IE00B19Z8W00.USD","LU0122379950.USD","BK4121","LU0070302665.USD","LU1815333072.USD","LU2125910336.SGD","LU0316494557.USD","LU2357305700.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648501421","title":"Arcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher Scientific to Advance Arct-032 for Cystic Fibrosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2648501421","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648501421?lang=en_us&edition=fundamental","pubTime":"2026-07-02 19:00","pubTimestamp":1782990000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nTUABDN7T4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARCT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648505766","title":"Arcturus Therapeutics initiated with a Buy at Freedom Broker","url":"https://stock-news.laohu8.com/highlight/detail?id=2648505766","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648505766?lang=en_us&edition=fundamental","pubTime":"2026-07-02 17:30","pubTimestamp":1782984608,"startTime":"0","endTime":"0","summary":"Freedom Broker initiated coverage of Arcturus Therapeutics (ARCT) with a Buy rating and $27 price target Arcturus is a clinical-stage mRNA medicine...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/arcturus-therapeutics-initiated-with-a-buy-at-freedom-broker-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/arcturus-therapeutics-initiated-with-a-buy-at-freedom-broker-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4007","BK4139","ARCT","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638454035","title":"Arcturus Therapeutics to Present at Jefferies Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2638454035","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638454035?lang=en_us&edition=fundamental","pubTime":"2026-05-27 04:01","pubTimestamp":1779825704,"startTime":"0","endTime":"0","summary":"Arcturus will present at the 2026 Jefferies Global Healthcare Conference in New York on June 4, 2026 at 9:20 a.m. ET.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDLbvm7Xw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARCT"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2635858347","title":"ARCT Rating Reiterated at Hold as High-Risk ARCT-032 CF Program Awaits Binary Phase 2 Readout; $9 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2635858347","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635858347?lang=en_us&edition=fundamental","pubTime":"2026-05-13 18:36","pubTimestamp":1778668584,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Andrew Fein has maintained their neutral stance on ARCT stock, giving a Hold rating on May 11. Andrew Fein has given his Ho...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/arct-rating-reiterated-at-hold-as-high-risk-arct-032-cf-program-awaits-binary-phase-2-readout-9-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/arct-rating-reiterated-at-hold-as-high-risk-arct-032-cf-program-awaits-binary-phase-2-readout-9-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARCT","CF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634213125","title":"Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Consensus Forecasts Have Become A Little Darker Since Its Latest Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2634213125","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634213125?lang=en_us&edition=fundamental","pubTime":"2026-05-12 18:26","pubTimestamp":1778581605,"startTime":"0","endTime":"0","summary":"As you might know, Arcturus Therapeutics Holdings Inc. ( NASDAQ:ARCT ) recently reported its first-quarter numbers...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-arct/arcturus-therapeutics-holdings/news/arcturus-therapeutics-holdings-inc-nasdaqarct-consensus-fore","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-arct/arcturus-therapeutics-holdings/news/arcturus-therapeutics-holdings-inc-nasdaqarct-consensus-fore","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NDX","NVIW.SI","ONEQ","FTEC","NQmain","QQQA","TECS","BK4139","QQQY","QYLG","QQQM","TQQY","PSQ","QID","SQQQ","IYW","QQQ","MNQmain","QQQJ","JEPQ","QLD","GPIQ",".IXIC","TQQQ","ARCT","QDTE","QQQE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633510533","title":"Arcturus Therapeutics Holdings Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2633510533","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633510533?lang=en_us&edition=fundamental","pubTime":"2026-05-08 06:44","pubTimestamp":1778193856,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics Holdings Inc reports results for the quarter ended March 31 - Earnings SummaryArcturus Therapeutics Holdings Inc ARCT.OQ reported a quarterly adjusted loss of 95 cents per share ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nL8N41K3LC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARCT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633771641","title":"Arcturus Therapeutics Holdings Inc - Appoints Dennis Mulroy as CFO Effective May 1, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2633771641","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633771641?lang=en_us&edition=fundamental","pubTime":"2026-05-08 05:02","pubTimestamp":1778187733,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nFWN41K1FX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARCT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633174255","title":"Arcturus Therapeutics CFO Dennis Mulroy files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2633174255","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633174255?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:33","pubTimestamp":1778186031,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics filed an initial Form 3 for Dennis Mulroy in his role as chief financial officer, dated May 1, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcturus Therapeutics Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 07, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDLWkB8s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633399176","title":"Arcturus Q1 FY26 net loss widens to $27 million; revenue drops to $2.06 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633399176","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633399176?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:02","pubTimestamp":1778184173,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics posted a net loss of $27 million, or  per share, for the quarter ended March 31, 2026, versus a net loss of $14.1 million, or  per share, a year earlier.Revenue slid to $2.1 million from $29.4 million, driven by lower collaboration revenue as it pivots from infectious disease vaccine development toward rare disease clinical programs.Total operating expenses fell to $31 million from $46.2 million, with R&D dropping to $21.5 million from $34.9 million on lower LUNAR-COVID and BARDA manufacturing and trial costs.Cash, cash equivalents and restricted cash were $213.4 million at March 31, down from $232.8 million at end-2025, with cash runway expected to extend beyond second-quarter 2028.Initiated enrollment in a 12-week open-label Phase 2 study of inhaled CF candidate ARCT-032, while FDA provided Type C meeting direction for pediatric development of OTC deficiency program ARCT-810 ahead of an end-of-Phase 2 meeting planned for H2 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDL864v2J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARCT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633763951","title":"BRIEF-Arcturus Therapeutics Q1 Net Income USD -26.964 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633763951","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633763951?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:01","pubTimestamp":1778184107,"startTime":"0","endTime":"0","summary":"BRIEF-Arcturus Therapeutics Q1 Net Income USD -26.964 Million\n\n\nMay 07 (Reuters) - Arcturus Therapeutics Q1 collaboration revenue USD 610 thousand.\n\nQ1 operating income USD -28.931 million\nQ1 basic EPS USD -0.95\nQ1 operating expenses USD 30.992 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nPLXE9A04C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARCT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633252175","title":"Arcturus Therapeutics Q1 Collaboration Revenue USD 610 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2633252175","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633252175?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:01","pubTimestamp":1778184062,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nPLXE9A04C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARCT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633117886","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2633117886","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633117886?lang=en_us&edition=fundamental","pubTime":"2026-05-07 18:00","pubTimestamp":1778148000,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Ares Comm. RE                                   1Q       .07    6:00 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVPT","AMPH","AMTX","ACIW","AFCG","ALT","AMLX","AKBA","AFRM","AMPX","ACLS","ACHR","ASTH","DDOG","AHR","AORT","BKV","AVNT","ACRE","ARTV","AAON","ALTG","ARGX","ALGM","AKAM","ALRM","ARLO","ABNB","BBDC","ACMR","ARWR","ASND","ASPN","AMN","ARHS","ABSI","APPN","ARW","AGO","ASC","ASMB","ARCT","BBIO","ANAB","AAOI","AURA","ATHM","ATLC","APYX","ABX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arcturusrx.com","stockEarnings":[{"period":"1week","weight":-0.132},{"period":"1month","weight":-0.178},{"period":"3month","weight":-0.3164},{"period":"6month","weight":-0.1701},{"period":"1year","weight":-0.5532},{"period":"ytd","weight":-0.0131}],"compareEarnings":[{"period":"1week","weight":-0.0154},{"period":"1month","weight":0.0031},{"period":"3month","weight":0.0467},{"period":"6month","weight":0.0746},{"period":"1year","weight":0.1835},{"period":"ytd","weight":0.09}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Arcturus Therapeutics Holdings Inc., a late-stage clinical messenger RNA medicines and vaccine company, focuses on the development of infectious disease vaccines and other products within liver and respiratory rare diseases. Its technology platforms include LUNAR lipid-mediated delivery and STARR mRNA. The company is developing ARCT-810 (LUNAR-OTC), a mRNA-based therapeutic candidate, which is in Phase 2 clinical trial for treating ornithine transcarbamylase deficiency; and ARCT-154 (LUNAR-COV19), a mRNA vaccine candidate that is in Phase 3 arm of a Phase 1/2/3 study in Vietnam for the treatment of COVID-19, as well as ARCT-032 (LUNAR-CF), a mRNA therapeutic candidate for cystic fibrosis. The company was founded in 2013 and is headquartered in San Diego, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.084619},{"month":2,"riseRate":0.538462,"avgChangeRate":0.016903},{"month":3,"riseRate":0.230769,"avgChangeRate":-0.051078},{"month":4,"riseRate":0.615385,"avgChangeRate":0.111259},{"month":5,"riseRate":0.538462,"avgChangeRate":0.081426},{"month":6,"riseRate":0.571429,"avgChangeRate":0.011692},{"month":7,"riseRate":0.5,"avgChangeRate":0.082376},{"month":8,"riseRate":0.538462,"avgChangeRate":0.072518},{"month":9,"riseRate":0.384615,"avgChangeRate":-0.052457},{"month":10,"riseRate":0.384615,"avgChangeRate":-0.077832},{"month":11,"riseRate":0.615385,"avgChangeRate":0.033635},{"month":12,"riseRate":0.307692,"avgChangeRate":-0.064746}],"exchange":"NASDAQ","name":"Arcturus Therapeutics Ltd.","nameEN":"Arcturus Therapeutics Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Arcturus Therapeutics Ltd.(ARCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Arcturus Therapeutics Ltd.(ARCT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Arcturus Therapeutics Ltd.,ARCT,Arcturus Therapeutics Ltd.股票,Arcturus Therapeutics Ltd.股票老虎,Arcturus Therapeutics Ltd.股票老虎国际,Arcturus Therapeutics Ltd.行情,Arcturus Therapeutics Ltd.股票行情,Arcturus Therapeutics Ltd.股价,Arcturus Therapeutics Ltd.股市,Arcturus Therapeutics Ltd.股票价格,Arcturus Therapeutics Ltd.股票交易,Arcturus Therapeutics Ltd.股票购买,Arcturus Therapeutics Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Arcturus Therapeutics Ltd.(ARCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Arcturus Therapeutics Ltd.(ARCT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction